| BMC Genomics | |
| A GWAS assessment of the contribution of genomic imprinting to the variation of body mass index in mice | |
| Research Article | |
| Yaodong Hu1  Guilherme JM Rosa2  Daniel Gianola3  | |
| [1] Department of Animal Sciences, University of Wisconsin - Madison, 1675 Observatory Dr., 53706, Madison, WI, USA;Department of Animal Sciences, University of Wisconsin - Madison, 1675 Observatory Dr., 53706, Madison, WI, USA;Department of Biostatistics and Medical Informatics, University of Wisconsin - Madison, 600 Highland Avenue, 53792, Madison, WI, USA;Department of Animal Sciences, University of Wisconsin - Madison, 1675 Observatory Dr., 53706, Madison, WI, USA;Department of Biostatistics and Medical Informatics, University of Wisconsin - Madison, 600 Highland Avenue, 53792, Madison, WI, USA;Department of Dairy Science, University of Wisconsin - Madison, 1675 Observatory Dr., 53706, Madison, WI, USA; | |
| 关键词: Epigenetics; Genomic imprinting; Genome-wide association studies; Missing heritability; Mouse body mass index; | |
| DOI : 10.1186/s12864-015-1721-z | |
| received in 2015-02-25, accepted in 2015-06-25, 发布年份 2015 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundGenomic imprinting is an epigenetic mechanism that can lead to differential gene expression depending on the parent-of-origin of a received allele. While most studies on imprinting address its underlying molecular mechanisms or attempt at discovering genomic regions that might be subject to imprinting, few have focused on the amount of phenotypic variation contributed by such epigenetic process. In this report, we give a brief review of a one-locus imprinting model in a quantitative genetics framework, and provide a decomposition of the genetic variance according to this model. Analytical deductions from the proposed imprinting model indicated a non-negligible contribution of imprinting to genetic variation of complex traits. Also, we performed a whole-genome scan analysis on mouse body mass index (BMI) aiming at revealing potential consequences when existing imprinting effects are ignored in genetic analysis.Results10,021 SNP markers were used to perform a whole-genome single marker regression on mouse BMI using an additive and an imprinting model. Markers significant for imprinting indicated that BMI is subject to imprinting. Marked variance changed from 1.218 ×10−4 to 1.842 ×10−4 when imprinting was considered in the analysis, implying that one third of marked variance would be lost if existing imprinting effects were not accounted for. When both marker and pedigree information were used, estimated heritability increased from 0.176 to 0.195 when imprinting was considered.ConclusionsWhen a complex trait is subject to imprinting, using an additive model that ignores this phenomenon may result in an underestimate of additive variability, potentially leading to wrong inferences about the underlying genetic architecture of that trait. This could be a possible factor explaining part of the missing heritability commonly observed in genome-wide association studies (GWAS).
【 授权许可】
CC BY
© Hu et al. 2015
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311107785998ZK.pdf | 5769KB | ||
| Fig. 2 | 2578KB | Image | |
| 12951_2015_155_Article_IEq75.gif | 1KB | Image | |
| Fig. 3 | 2497KB | Image | |
| Scheme. 1 | 8432KB | Image | |
| MediaObjects/13068_2023_2416_MOESM4_ESM.xls | 40KB | Other | |
| Fig. 2 | 265KB | Image | |
| MediaObjects/13068_2023_2416_MOESM5_ESM.xls | 44KB | Other | |
| MediaObjects/13068_2023_2416_MOESM6_ESM.xls | 54KB | Other | |
| 12951_2015_155_Article_IEq76.gif | 1KB | Image | |
| MediaObjects/12888_2023_5218_MOESM1_ESM.docx | 893KB | Other | |
| 12951_2015_155_Article_IEq77.gif | 1KB | Image | |
| Fig. 4 | 603KB | Image | |
| Fig. 1: The conceptual framework for adherence to treatment guidelines in private drug outlets in Kisumu, Kenya | 398KB | Image | |
| MediaObjects/12888_2023_5220_MOESM1_ESM.docx | 69KB | Other | |
| Fig. 2 | 1904KB | Image | |
| 12951_2016_246_Article_IEq5.gif | 1KB | Image | |
| Fig. 10 | 2860KB | Image | |
| Fig. 1 | 127KB | Image | |
| Fig. 5 | 629KB | Image | |
| MediaObjects/13046_2023_2842_MOESM1_ESM.docx | 6521KB | Other | |
| Fig. 3 | 204KB | Image | |
| 12951_2017_255_Article_IEq48.gif | 1KB | Image | |
| Fig. 1 | 334KB | Image | |
| Fig. 1 | 105KB | Image | |
| Fig. 6 | 1312KB | Image | |
| Fig. 5 | 993KB | Image | |
| 12951_2016_246_Article_IEq8.gif | 1KB | Image | |
| 42004_2023_1031_Article_IEq16.gif | 1KB | Image | |
| 12951_2016_246_Article_IEq9.gif | 1KB | Image | |
| 42004_2023_1031_Figa_HTML.png | 4KB | Image | |
| MediaObjects/12888_2023_5225_MOESM1_ESM.docx | 1153KB | Other | |
| MediaObjects/42004_2023_1031_MOESM1_ESM.pdf | 4101KB | ||
| MediaObjects/12951_2023_2146_MOESM1_ESM.doc | 46918KB | Other | |
| Fig. 6 | 412KB | Image | |
| Fig. 5 | 3768KB | Image | |
| Fig. 1 | 182KB | Image | |
| 12936_2017_1904_Article_IEq1.gif | 1KB | Image | |
| 12951_2017_255_Article_IEq49.gif | 1KB | Image | |
| MediaObjects/41408_2023_927_MOESM6_ESM.tif | 3545KB | Other | |
| 12951_2017_255_Article_IEq50.gif | 1KB | Image | |
| MediaObjects/12944_2023_1941_MOESM2_ESM.xlsx | 10KB | Other | |
| 12951_2016_223_Article_IEq1.gif | 1KB | Image | |
| Scheme 1 | 2400KB | Image | |
| MediaObjects/13046_2023_2857_MOESM1_ESM.pdf | 6527KB | ||
| Fig. 2 | 2232KB | Image | |
| Fig. 1 | 1626KB | Image | |
| Fig. 1 | 573KB | Image | |
| Fig. 10 | 4904KB | Image | |
| Fig. 4 | 371KB | Image | |
| Fig. 1 | 245KB | Image | |
| MediaObjects/12974_2023_2910_MOESM3_ESM.tif | 3321KB | Other |
【 图 表 】
Fig. 1
Fig. 4
Fig. 10
Fig. 1
Fig. 1
Fig. 2
Scheme 1
12951_2016_223_Article_IEq1.gif
12951_2017_255_Article_IEq50.gif
12951_2017_255_Article_IEq49.gif
12936_2017_1904_Article_IEq1.gif
Fig. 1
Fig. 5
Fig. 6
42004_2023_1031_Figa_HTML.png
12951_2016_246_Article_IEq9.gif
42004_2023_1031_Article_IEq16.gif
12951_2016_246_Article_IEq8.gif
Fig. 5
Fig. 6
Fig. 1
Fig. 1
12951_2017_255_Article_IEq48.gif
Fig. 3
Fig. 5
Fig. 1
Fig. 10
12951_2016_246_Article_IEq5.gif
Fig. 2
Fig. 1: The conceptual framework for adherence to treatment guidelines in private drug outlets in Kisumu, Kenya
Fig. 4
12951_2015_155_Article_IEq77.gif
12951_2015_155_Article_IEq76.gif
Fig. 2
Scheme. 1
Fig. 3
12951_2015_155_Article_IEq75.gif
Fig. 2
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]
- [57]
- [58]
- [59]
- [60]
- [61]
- [62]
- [63]
- [64]
- [65]
- [66]
- [67]
- [68]
- [69]
PDF